The Unitary Patent and the Unified Patent Court: A Guide to Ratification, Implementation, and Strategies for Biosimilars and Originator Biologics

December 1, 2022 8:00am

The Unitary Patent and the Unitary Patent Court were designed to achieve a simpler, cost-effective means of protecting and enforcing patents in Europe. While it is certain that the UPC’s decisions will have pan-European effect, it is less clear how the UPC could impact biosimilar medicines. This session will analyze the changes under the UPC and UP and provide attendees with a handbook for the future. Topics of discussion will include:

    • Considering the costs and benefits of the system for biologic patent applications
    • Weighing the decision to opt out
    • Monitoring competitor patents toward launching UPC revocation actions
    • Strategically using divisional applications during the transition period
    • Understanding the territorial scope of protection and the role protocols play in the biologics space
    • Predicting the impact to litigation and legal certainty
    • Detailing the non-exclusive jurisdiction for all national validations of European patents and biologics patents in particular